• Netilmicin sulfate, a new aminoglycoside antibiotic, was administered to ten patients with thermal burns who were suffering from septic complications, usually burn wound sepsis. There were seven survivors. Eighty-three percent of all clinical isolates recovered showed sensitivity to the drug. No renal or auditory side effects were noted in any of the patients.
(Arch Surg 114:28-30, 1979)
Munster AM. Netilmicin: A New Aminoglycoside in the Treatment of Septic Burn Patients. Arch Surg. 1979;114(1):28–30. doi:10.1001/archsurg.1979.01370250030005
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: